MFIM
CSBR icon

Mesirow Financial Investment Management’s Champions Oncology CSBR Stock Holding History

Mesirow Financial Investment Management’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.3K Hold
15,800
– – ﹤0.01% 517
2026
Q1 		$90.8K Buy
15,800
+5,500
+53% +$34.9K ﹤0.01% 505
2025
Q4 		$71.2K Sell
10,300
-1,700
-14% -$11.3K ﹤0.01% 478
2025
Q3 		$77.7K Hold
12,000
– – ﹤0.01% 543
2025
Q2 		$88.4K Hold
12,000
– – ﹤0.01% 519
2025
Q1 		$104K Hold
12,000
– – ﹤0.01% 562
2024
Q4 		$103K Hold
12,000
– – ﹤0.01% 575
2024
Q3 		$58.4K Hold
12,000
– – ﹤0.01% 575
2024
Q2 		$62K Sell
12,000
-380
-3% -$1.85K ﹤0.01% 493
2024
Q1 		$60.7K Buy
+12,380
New +$72.5K ﹤0.01% 505

Other funds holding CSBR

Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Mesirow Financial Investment Management's CSBR Position: Q2 2026 in Review

Mesirow Financial Investment Management held its Champions Oncology (CSBR) position steady in Q2 2026 at 15,800 shares worth $97.3K. The position accounts for ﹤0.01% of the portfolio, ranked #517.

Mesirow Financial Investment Management first reported a position in CSBR in Q1 2024 and has held it in 10 quarters since. The position peaked at $104K in Q1 2025. 4 funds tracked by Wall St. Rank hold CSBR as of Q2 2026.

  • Mesirow Financial Investment Management held 15,800 shares of Champions Oncology worth $97.3K as of Q2 2026.
  • Mesirow Financial Investment Management left its Champions Oncology share count unchanged in Q2 2026.
  • Champions Oncology made up ﹤0.01% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #517 holding.
  • Mesirow Financial Investment Management first reported a position in Champions Oncology in Q1 2024 and has held it in 10 quarters since.
  • Mesirow Financial Investment Management's Champions Oncology position peaked at $104K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.